While millions of Americans suffer in agony from chronic back pain, the pharmaceutical industry has finally decided to investigate the INFECTION causing it rather than pushing more opioids on desperate patients.
At a Glance
- A revolutionary new antibiotic, PP353, shows promise in treating chronic lower back pain by targeting bacterial infections
- Nearly 28% of US adults suffer from chronic lower back pain, with a quarter of these cases linked to bacterial infections in spinal discs
- Clinical trials showed 60% of participants experienced significant improvements lasting up to 12 months after treatment
- The treatment offers a non-opioid alternative amid America’s devastating addiction crisis
- The drug requires just two injections four days apart rather than endless prescriptions or surgical intervention
Big Pharma Finally Discovers Root Cause Instead of Symptom Masking
For decades, Americans suffering from chronic lower back pain have been shuffled between doctors’ offices, physical therapy appointments, and pharmacies, all while being told their excruciating pain was just something they’d have to live with. The medical establishment’s brilliant solution? Here, take these highly addictive opioids that will destroy your life but won’t actually fix anything!
But now, a UK-based pharmaceutical company has done something revolutionary – they’ve actually investigated what causes chronic back pain in many patients. Turns out, for about 25% of chronic sufferers, it’s a bacterial infection in the spinal discs. Who would have thought treating the actual cause might help?
Persica Pharmaceuticals has developed PP353, a combination of the antibiotic linezolid, iohexol, and a thermosensitive gel specifically designed to target these infections. Early clinical trials with 44 patients across the UK, Spain, Denmark, and New Zealand showed astonishing results – 60% of participants reported significant improvements that lasted for at least 12 months after treatment. Most amazingly, these improvements happened without pumping patients full of addictive substances that have fueled one of the worst public health crises in American history.
Yesterday was a tough day – the 5 year anniversary of the passing of my mother aged only 68. Her premature death and unnecessary suffering during the final 4 weeks in hospital were a result of system failures especially lack of action in dealing with two of the biggest enemies of… pic.twitter.com/wZYEcXwFlD
— Dr Aseem Malhotra (@DrAseemMalhotra) November 30, 2023
The Epidemic You’re Not Supposed to Question
Chronic lower back pain has become America’s silent epidemic. It’s the leading cause of doctor visits, missed workdays, and disability claims in the country. A staggering 28% of US adults suffer from this debilitating condition. For too long, the standard practice has been to throw painkillers at the problem while ignoring the underlying causes.
When those fail, patients get shuttled to surgeons for expensive, often ineffective procedures. All the while, Big Pharma rakes in billions from medications that mask symptoms rather than treat causes, creating a perpetual cycle of dependency that’s fantastic for their bottom line.
“If we can get these 25% of the patients with chronic low back pain back to work, back to no medications, back to no more disability, then I think [that] will be the massive gamechanger for the future”, says Dr. Shiva Tripathi.
What’s truly remarkable about this breakthrough is that researchers identified that these bacterial infections cause damage to bones, nerve irritation, and inflammation – creating what are called “Modic changes” that can be detected by MRI.
In the clinical trial, patients reported a 3.4-point reduction in pain from baseline and experienced statistically significant reductions in disability. And here’s the kicker – the treatment involves just TWO injections four days apart. Compare that to a lifetime of prescription refills that keep you dependent on the pharmaceutical industry’s generosity.
A Solution to the Crisis Government Created
The timing couldn’t be better as America continues to grapple with an opioid epidemic that was largely manufactured by pharmaceutical companies and enabled by government agencies that were supposed to protect us. According to market research, the opioid addiction market is projected to grow from $2 billion in 2023 to $2.4 billion in 2033. That’s right – there’s now a multi-billion dollar industry dedicated to treating the addiction caused by the “treatment” for chronic pain. Does anyone else see the insanity in this system?
“Modern medicine has largely failed people with chronic – in other words, long-term – back pain. But there is little evidence that interventions using surgery or injections, or even taking medicines, makes much difference for the vast majority of people with chronic low back pain”, says Dr. Benjamin Ellis.
Market research suggests millions worldwide could benefit from this treatment, including 2 million Americans and hundreds of thousands in other countries. Of course, before Americans can access this potentially life-changing treatment, it will need to navigate the FDA’s labyrinthine approval process.
Persica is planning larger trials to confirm the drug’s effectiveness, but those of us who understand how our regulatory system works know that it could be years before this treatment is widely available to those who need it most. In the meantime, keep taking those pills, America – they’re “safe and effective,” we promise!
